17 found
Order:
  1.  19
    Solidarity and Justice as Guiding Principles in Genomic Research.Rogeer Hoedemaekers, Bert Gordijn & Martien Pijnenburg - 2007 - Bioethics 21 (6):342–350.
  2.  54
    Justice and Solidarity in Priority Setting in Health Care.Rogeer Hoedemaekers & Wim Dekkers - 2003 - Health Care Analysis 11 (4):325-343.
    During the last decade a “technical” approach has become increasingly influential in health care priority setting. The various country reports illustrate, however, that non-technical considerations cannot be avoided. As they often remain implicit in health care package decisions, this paper aims to make these normative judgements an explicit part of the procedure. More specifically, it aims to integrate different models of distributive justice as well as the principle of solidarity in four different phases of a decision-making procedure, and to identify (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  3.  74
    Does an Appeal to the Common Good Justify Individual Sacrifices for Genomic Research?Rogeer Hoedemaekers, Bert Gordijn & Martien Pijnenburg - 2006 - Theoretical Medicine and Bioethics 27 (5):415-431.
    In genomic research the ideal standard of free, informed, prior, and explicit consent is believed to restrict important research studies. For certain types of genomic research other forms of consent are therefore proposed which are ethically justified by an appeal to the common good. This notion is often used in a general sense and this forms a weak basis for the use of weaker forms of consent. Here we examine how the notion of the common good can be related to (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  4.  32
    Key Concepts in Health Care Priority Setting.Rogeer Hoedemaekers & Wim Dekkers - 2003 - Health Care Analysis 11 (4):309-323.
    In decisions about inclusion (or exclusion) of health care services in the benefit package, different interpretations of notions like health, health risk, disease, quality of life or necessary care often remain implicit. Yet they can lead to different benefit package decisions. After a brief discussion of these concepts in definitions of the goals of medicine, the various value-judgements implicit in interpretations of key notions in health care are analysed and conclusions are drawn with regard to the composition of decision making (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  5.  43
    Geneticization: The Cyprus Paradigm.Henk ten Have & Rogeer Hoedemaekers - 1998 - Journal of Medicine and Philosophy 23 (3):274-287.
    Geneticization is a broad term referring to several related processes such as a spreading tendency to use a genetic model of disease explanation, a growing influence of genetics in medical practice, and the slow changing of individual and societal attitudes towards reproduction, prevention and control of disease. These processes can be demonstrated in medical literature on preventive genetic screening and counselling programs for β-thalassaemia in Cyprus, the United Kingdom and Canada. The preventive possibilities of the new genetic and diagnostic technologies (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  6.  10
    Problematic Notions in Dutch Health Care Package Decisions.Rogeer Hoedemaekers & Wija Oortwijn - 2003 - Health Care Analysis 11 (4):287-294.
    This paper discusses the problematic and sometimes implicit nature of some central notions and criteria used in debates about inclusion (or exclusion) of health care services in the health care benefit package. An analysis of discussions about four health care services—lungtransplantation, statins, (sildenafil (viagra) and rivastigmine—illustrates a case-by-case approach and inconsistent use of criteria, which present a challenge to develop a decision-making procedure in which important criteria or central notions can be discussed explicitly.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  7.  18
    Introduction: Towards Better Integration of Normative Judgements in Health Care Package Decisions. [REVIEW]Rogeer Hoedemaekers - 2003 - Health Care Analysis 11 (4):275-278.
  8.  23
    Commercialisation of Genetic Diagnostic Services.Rogeer Hoedemaekers & Henk ten Have - 1998 - Medicine, Health Care and Philosophy 1 (3):217-224.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  9.  71
    The Concept of Abnormality in Medical Genetics.Rogeer Hoedemaekers & Henk ten Have - 1999 - Theoretical Medicine and Bioethics 20 (6):537-561.
    This paper explores usage of the concept ofabnormality in medical genetics and proposesdirectives for more careful usage of this concept.The conceptual difficulties are first explored, thena model is developed to assess actual usage, followedby analysis of a sample of genetic textbooks andgenetics literature. It appears that fact andvaluation are often intermingled, that referencestandards used to define 'genetic abnormalities' areoften not clear and that the concept of abnormality isoften used independent of the degree of certainty withwhich the altered genetype develops into (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  10.  24
    Commercialization, Patents and Moral Assessment of Biotechnology Products.Rogeer Hoedemaekers - 2001 - Journal of Medicine and Philosophy 26 (3):273 – 284.
    The biotechnology patent debates have revealed deep moral concerns about basic genetics research, RD and specific biotechnological products, concerns that are seldom taken into consideration in Technology Assessment. In this paper important moral concerns are examined which appear at the various stages of development of a specific genetic product: a predictive genetic test. The purpose is to illustrate the need for a more contextual approach in technology assessment, which integrates the various forms of interaction between bio-technology and society or societal (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  11.  46
    Is There a Unique Moral Status of Human DNA That Prevents Patenting?Rogeer Hoedemaekers & Wim Dekkers - 2001 - Kennedy Institute of Ethics Journal 11 (4):359-386.
    : The gene patenting debate, which proved to be a focal point for divergent moral concerns about recent developments in genome research and biotechnology, has revealed that the moral status of DNA is not clear. One of the arguments used to stop undesirable developments was that DNA possesses a unique status, which renders it unfit for patenting. This paper investigates the allegedly unique (moral) status of genetic material and the information it holds from different perspectives. Several properties of DNA prove (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  27
    Human Gene Patents: Core Issues in a Multi-Layered Debate. [REVIEW]Rogeer Hoedemaekers - 2001 - Medicine, Health Care and Philosophy 4 (2):211-221.
    After ten years of debate Directive 98/44/EG on the legal protection of biotechnological inventions was adopted in 1998. This directive takes decisions on some controversial bioethical and legal issues and offers the European biotech industries more space to develop their inventions, but leaves a number of philosophical and moral issues unresolved. This paper distinguishes between different layers in the debate and maps its modes of argumentation. Major philosophical, ethical and conceptual issues are located. It is argued that further analysis of (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  34
    Euroscreen 2: Zu einer gemeinsamen Versicherungs- und Kommerzialisierungspolitik und zu einer Politik des öffentlichen Bewusstseins über Genetik. [REVIEW]Ruth Chadwick, Henk ten Have, Rogeer Hoedemaekers, Jørgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing - 2000 - Ethik in der Medizin 12 (4):269-273.
    Direct download (4 more)  
    Translate
     
     
    Export citation  
     
    Bookmark  
  14.  52
    The Ontological Status of Human DNA: Is It Not First and Foremost a Biological ``File Self''?Rogeer Hoedemaekers & Wim Dekkers - 2002 - Theoretical Medicine and Bioethics 23 (4-5):377-395.
    This paper investigates which of the variouslegal notions proposed for human DNA is themost appropriate from an ontological viewpoint – unique legal status, private property, commonproperty, person, or information. The focus is onthe difficulties that private property, commonproperty and person present. By usingHarré''s notion of ``file-self'''' we arguethat, ontologically, the most appropriate legalnotion to be applied is information. This hasconsequences for storage, control and use ofgenetic information as well as identifiablehuman body material.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  15.  22
    Euroscreen 2: Towards Community Policy on Insurance, Commercialization and Public Awareness.Ruth Chadwick, Henk ten Have, Rogeer Hoedemaekers, Jrgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing - 2001 - Journal of Medicine and Philosophy 26 (3):263-272.
    The project Euroscreen 2 has examined genetic screening and testing with particular reference to implications for insurance, commercialization through marketing of genetic tests direct to the public, and issues surrounding raising public awareness of these and other developments in genetics, including the practical experiment of a Gene Shop. This paper provides a snapshot of the three year project. The study groups work included monitoring developments in different European countries and exploring possibilities for regulation in insurance and commercialization together with public (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  16.  9
    The Advent of the 'Personal Pill'.Rogeer Hoedemaekers, David Badcott & Bert Gordijn - 2001 - Ethical Perspectives 8 (1):50-58.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  17. Euroscreen 2: Zu einer gemeinsamen Versicherungs- und Kommerzialisierungspolitik und zu einer Politik des oeffentlichen Bewusstseins ueber Genetik.Urban Wiesing, Ruth Chadwick, Henk ten Have, Rogeer Hoedemaekers, Joergen Husted, Mairi Levitt, Tony McGleenan & Darren Shickle - 2000 - Ethik in der Medizin 12 (4):269-273.
    No categories
    Translate
     
     
    Export citation  
     
    Bookmark